The Canadian COVID-19 Prospective Cohort Study (NCT05125510)
🩺 Plain-English Summary (8th-Grade Level)
The CANCOV study will be the first Canadian study to provide a comprehensive evaluation of early, and 1-year, outcomes of outpatient and hospitalized COVID-19 survivors and their family caregivers, their varied trajectories and associated clinical risk factors. The overall objectives are to determine short- (in hospital) and longer-term (1, 3, 6 and 12 months post-acute hospital discharge) outcomes COVID-19+ patients across the spectrum of symptom severity, including outpatients and inpatients from GIM and ICU wards and their caregivers, and the clinical, sociodemographic, multi-omic predictors of these outcomes. By leveraging expertise from investigators across disciplines and divisions, this study presents a suite of complementary projects that explore the genetic, transcriptomic, epigenomic and immunologic evaluation of COVID-19 infection across the illness and recovery trajectory during the acute illness and in the context of multidimensional long-term outcomes. As there continues to be need for longer term follow up and research on Long-COVID, this study has added an optional extension to include 2-year, 3-year, 4-year and 5 year outcomes.
Who can join: Review the eligibility criteria below.
Location: Alberta Health Services — Calgary, Alberta
Age range: 16 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (14 Sites)
- Alberta Health Services — Calgary, Alberta
- Providence Healthcare — Vancouver, British Columbia
- Health Sciences Centre and St. Boniface Hospital and Grace Hospital — Winnipeg, Manitoba
- William Osler Health System — Etobicoke, Ontario
- St Joseph's Health Centre — Hamilton, Ontario
- The Ottawa Hospital — Ottawa, Ontario
- Unity Health (St Michaels Health Centre_ — Toronto, Ontario
- Mount Sinai Hospital — Toronto, Ontario
- University Health Network, Osteoporosis Department — Toronto, Ontario
- Hospital for Sick Children — Toronto, Ontario
- Michael Garron Hospital — Toronto, Ontario
- McGill University Health Centre — Montreal, Quebec
- Montreal Jewish General — Montreal, Quebec
- University of Sherbrooke — Sherbrooke, Quebec
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Covid19
- Pediatric COVID Outcomes Study (PECOS) — Washington D.C., District of Columbia
- SedAting With Volatile Anesthetics Critically Ill COVID-19 Patients in ICU: Effects On Ventilatory Parameters And Survival — Edmonton, Alberta
- COVID-FISETIN: Pilot in SARS-CoV-2 of Fisetin to Alleviate Dysfunction and Inflammation — Rochester, Minnesota
- Post Acute Sequelae of COVID-19 — Nashville, Tennessee
- Lung Structure-Function In Survivors of Mild and Severe COVID-19 Infection — Hamilton, Ontario
Explore by condition: All Covid19 clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.